Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyRobert F Ozols, Roy S Herbst, Yolonda L Colson, et al.Blood|June 18, 2011
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology GroupJinghui Zhang, Charles G Mullighan, Richard C Harvey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4Anne L Angiolillo, Reuven J Schore, Meenakshi Devidas, et al.Blood|September 26, 2012
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.Pediatric Blood & Cancer|November 18, 2014
Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3)ZoAnn E Dreyer, Joanne M Hilden, Tamekia L Jones, et al.Blood|November 3, 2009
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaHuining Kang, I-Ming Chen, Carla S Wilson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2005
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyRoy S Herbst, Dean F Bajorin, Harry Bleiberg, et al.Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
JAK mutations in high-risk childhood acute lymphoblastic leukemiaCharles G Mullighan, Jinghui Zhang, Richard C Harvey, et al.Blood|February 28, 2012
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group studyI-Ming Chen, Richard C Harvey, Charles G Mullighan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemiaHeng Xu, Cheng Cheng, Meenakshi Devidas, et al.Pageof 10